Company
About us
Acticor Team
Board of Directors
investors & Partners
Prizes & Awards
Our Product
Our product: Glenzocimab
GPVI / GLENZOCIMAB in brief
in acute ischemic stroke
⮑ Positive results actimis study
in other indications
Pipeline
About stroke
Key figures
What is a stroke?
Media
Press Releases
Publications
Media Coverage
Events
Investors
Welcome
Corporate Presentation
Share Overview
Shareholders' Meeting
Regulated Information
Financial Agenda
COntact
Investors
Financial Information
pp
2023
2022
2021
PDF
June 30, 2022
Half-year financial report – June 30, 2022
PDF
April 27, 2022
Availability of the 2021 Universal registration document and the preparatory documents for the combined general meeting of May 12, 2022
PDF
April 27, 2022
Universal Registration Document - 2021
PDF
March 30, 2022
2021 full year financial results and update on clinical development
→ Welcome
→ Corporate Presentation
→ Share Overview
→ Shareholders' Meeting
→ Regulated Information
→ Financial Information
→ Other Regulated Information
→ Governance
→ Financial Agenda
→ Contact
Ask Us Your Questions
Subscribe To Email Alert
